Supplementary Table 1. Basic sample characteristics FEP (n=51) ARMS (n=46) Controls (n=53) Test statistic. F=18.6, df=2

Similar documents
the formation of psychotic experiences across different stages of early psychosis in daily life.

King s Research Portal

Office Practice Coding Assistance - Overview

Supplementary Online Content

University of Groningen

Supplementary appendix

Evidence That a Psychopathology Interactome Has Diagnostic Value, Predicting Clinical Needs: An Experience Sampling Study

Supplementary Methods

Community Services - Eligibility

Supplementary Online Content

Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia

CRITICAL ANALYSIS PROBLEMS

Experience in context. Mood. Psychotic Symptoms Daily stress. Daily stress

NeuRA Obsessive-compulsive disorders October 2017

Brief Report. Resilience, Recovery Style, and Stress in Early Psychosis

Results. NeuRA Forensic settings April 2016

Use of Anti-Psychotic Agents in Irish Long Term Care Residents with Dementia

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Mending the Mind: treatment of the severely mentally ill

Mood Disorders for Care Coordinators

The social world of the socially anhedonic: Exploring the daily ecology of asociality

Longest running mental health survey series using consistent methods

THREE YEAR OUTCOMES IN AN EARLY INTERVENTION SERVICE FOR PSYCHOSIS IN A MULTICULTURAL AND MULTIETHNIC POPULATION

Challenges to Recovery Following Early Psychosis: Implications of Recovery Rate and Timing

Ethnicity and suicide attempt: analysis in bipolar disorder and schizophrenia

Data Analysis in Practice-Based Research. Stephen Zyzanski, PhD Department of Family Medicine Case Western Reserve University School of Medicine

NeuRA Schizophrenia diagnosis June 2017

Bipolar Disorder. Ashleigh Pigusch

efigure. Directed Acyclic Graph to Determine Whether Familial Factors Exist That Contribute to Both Eating Disorders and Suicide

10 years of CBT at PEPP-Montréal: A service level perspective

NeuRA Schizophrenia diagnosis May 2017

Lithium in bipolar disorders.

Method. NeuRA Positive symptoms June 2017

Supplemental Data. Inclusion/exclusion criteria for major depressive disorder group and healthy control group

GOALS FOR THE PSCYHIATRY CLERKSHIP

Early Stages of Psychosis. Learning Objectives

University of Groningen. Metabolic risk in people with psychotic disorders Bruins, Jojanneke

Diagnosed with Psychotic

SCHIZOPHRENIA and PSYCHOSES

Because of the many changes in

UnitedHealthcare Community (UHCCP) Louisiana Clinical Program Guidelines Record Supplemental Tool

Supplementary figures and tables. Figure A: Study schematic

PSYCH 335 Psychological Disorders

It's Cycling, Not Polarity Understanding and Diagnosing the Bipolar Spectrum

ACOEM Commercial Driver Medical Examiner Training Program

12/17/2012. Unnecessary Drugs

Patterns of illness and care over the 5 years following onset of psychosis in different ethnic groups; the GAP-5 study

Childhood neglect predicts the course of major depression in a tertiary care sample: a follow-up study

The Louis de la Parte Florida Mental Health Institute

Psychosis, Mood, and Personality: A Clinical Perspective

Environmental Social Stress, Paranoia and Psychosis Liability: A Virtual Reality Study

Results. NeuRA Family relationships May 2017

INDIANA HEALTH COVERAGE PROGRAMS

Results. NeuRA Treatments for dual diagnosis August 2016

King s Research Portal

Adult Psychiatric Morbidity Survey (APMS) 2014 Part of a national Mental Health Survey Programme

Supplementary Online Content

METHODS RESULTS. Supported by funding from Ortho-McNeil Janssen Scientific Affairs, LLC

University of Groningen. Metabolic risk in people with psychotic disorders Bruins, Jojanneke

Bipolar Disorder 4/6/2014. Bipolar Disorder. Symptoms of Depression. Mania. Depression

Alcoholism. Psychiatry. Alcoholism. Alcoholism. Certification. Certification

Type of intervention Secondary prevention and treatment. Economic study type Cost-effectiveness analysis.

EMDR and Severe Mental Disorders

Liz Clark, D.O., MPH & TM FAOCOPM

Program Outline. DSM-5 Schizophrenia Spectrum and Psychotic Disorders: Knowing it Better and Improving Clinical Practice.

Prevalence of Comorbidity and Pattern Drug Use among Children with Attention-deficit hyperactivity disorder: A Single Center in Thailand

INDIANA HEALTH COVERAGE PROGRAMS

Donna L. Coffman Joint Prevention Methodology Seminar

Depression and schizophrenia Upthegrove, Rachel; Marwaha, Steven; Birchwood, Maximillian

EARLY ONSET SCHIZOPHRENIA

Unemployment, social isolation, achievement expectation mismatch and psychosis: findings from the ÆSOP Study

Hypomania spectrum disorder in adolescence: a 15-year follow-up of non-mood morbidity in adulthood

AMPS : A Quick, Effective Approach To The Primary Care Psychiatric Interview

Cognitive Behavioral Treatment of Delusions and Paranoia. Dennis Combs, Ph.D. University of Tulsa

Accurate Diagnosis of Primary Psychotic Disorders

Borderline personality disorder: what role for medication?

Social anxiety disorder in early phase psychosis: the role of shame sensitivity and diagnosis concealment

University of Groningen. Neurological soft signs in schizophrenia and mood disorders Boks, Marco Paul Maria

Results. NeuRA Mindfulness and acceptance therapies August 2018

Psychiatric morbidity among women prisoners newly committed and amongst remanded and sentenced women in the Irish prison system

S P O U S A L R ES E M B L A N C E I N PSYCHOPATHOLOGY: A C O M PA R I SO N O F PA R E N T S O F C H I LD R E N W I T H A N D WITHOUT PSYCHOPATHOLOGY

Leslie H. Brown, Paul J. Silvia, Inez Myin-Germeys, & Thomas R. Kwapil (2007). When the

Research Protocol for REAP Bipolar Disorder (REAP-BD)

A Pilot Study of Interpersonal Psychotherapy for Depressed Women with Breast Cancer

Supplementary Online Content

University of Groningen. Children of bipolar parents Wals, Marjolein

Childhood predictors of future psychiatric morbidity in offspring of mothers with psychotic disorder

NeuRA Schizophrenia diagnosis October 2017

Study Data Excluded Reason for Exclusions

4. General overview Definition

EVIDENCE AND PERSPECTIVES IN EARLY RECOGNITION AND INTERVENTION FOR PSYCHOSIS and BEYOND. Patrick McGorry

R (paliperidone palmitate) Clinical Study Report R SCA-3004

Social Disadvantage: Cause or Consequence of Impending Psychosis?

Are All Older Adults Depressed? Common Mental Health Disorders in Older Adults

Discharges against medical advice

Use of Mood Stabilizers to launch the use of combination treatments with mood stabilizers and antipsichotics for a variety of conditions, such as cont

PROVIDED IN RESPONSE TO YOUR UNSOLICITED REQUEST FOR INFORMATION

AT RISK MENTAL STATES IN PSYCHOSIS AND SCHIZOPHRENIA IN CHILDREN AND YOUNG PEOPLE

Demonstrating multilevel structural equation modeling for testing mediation: Effects of self-critical perfectionism on daily affect

Transcription:

This supplementary material accompanies the article: Klippel, A., Myin-Germeys, I., Chavez-Baldini, U., Preacher, K. J., Kempton, M., Valmaggia, L., Calem, M., So, S., Beards, S., Hubbard, K., Gayer-Anderson, C., Onyejiaka, A., Wichers, M., McGuire, P., Murray, R., Garety, P., van Os, J., Wykes, T., Moran, C., & Reininghaus, U. (2017). Modeling the interplay between psychological processes and adverse, ful contexts and in pathways to psychosis: An experience sampling study. Schizophrenia Bulletin, 43, 302-315. Supplementary Table 1. Basic sample characteristics FEP (n=51) ARMS (n=46) Controls (n=53) Age (years), mean (S.D.) 28.3 (8.6) 23.6 (4.7) 35.0 (12.6) Gender, n (%) Men 28 (54.9) 21 (45.7) 25 (47.2) Women 23 (45.1) 25 (54.4) 28 (52.8) Ethnicity, n (%) White British 14 (27.5) 17 (37.0) 25 (47.2) Black African 17 (33.3) 7 (15.2) 8 (15.1) Black Caribbean 11 (21.6) 7 (15.2) 6 (11.3) Asian 1 (2.0) 1 (2.2) 3 (5.7) White Other 4 (7.8) 5 (10.9) 5 (9.4) Other 4 (7.8) 9 (19.6) 6 (11.3) Place of birth, n (%) UK-born 32 (62.7) 34 (73.9) 33 (62.3) Non-UK-born 19 (37.3) 12 (26.1) 20 (37.7) Level of education, n (%) School 17 (33.3) 13 (28.9) 8 (15.1) Further 25 (49.0) 24 (53.3) 15 (28.3) Higher 9 (17.7) 8 (17.8) 30 (56.6) Test statistic F=18.6, df=2 p <0.001 χ 2 =1.0, df=2 0.612 χ 2 =14.0, df=10 0.174 χ 2 =1.9, df=2 0.396 χ 2 =24.3, df=4 Employment status, n (%) Unemployed 30 (58.8) 15 (32.6) 5 (9.4) χ 2 =28.5, Other 21 (41.2) 31 (67.4) 48 (90.6) df=2 OPCRIT disorder diagnosis a, n (%) Schizophrenia 15 (31.3) Delusional disorder 3 (6.3) Schizoaffective disorder 3 (6.3) Manic psychosis 7 (14.6) Depressive psychosis 7 (14.6) disorder NOS 13 (27.1) <0.001 <0.001 SCID Comorbid affective disorder diagnosis, n (%) Mood disorder 5 (10.9) Anxiety disorder 15 (32.6) Mood and anxiety disorder 3 (6.5) Psychotropic medication b, n (%) Antipsychotic c 40 (81.6) 5 (11.9) 0 (0.0) Atypical 36 (76.6) 5 (11.9) 0 (0.0) Typical 1 (2.1) 0 (0.0) 0 (0.0) Atypical and typical 1 (2.1) 0 (0.0) 0 (0.0) Antidepressant 11 (22.9) 17 (40.5) 0 (0.0) Other 12 (25.0) 4 (9.5) 9 (17.0) None 4 (8.2) 22 (52.4) 44 (83.0) Note: FEP, First-Episode Psychosis; ARMS, At-Risk Mental State for psychosis; S.D., standard deviation; df, degrees of freedom; OPCRIT, Operational Criteria system; SCID, Structured Clinical Interview for DSM Disorders; Missing values: a 3, b 6 c Antipsychotic medication in ARMS individuals was not for a psychotic episode (see exclusion criteria)

Supplementary Table 2. Aggregate ESM scores for, negative affect, aberrant, threat and psychotic in FEP, ARMS, and controls FEP ARMS Controls FEP vs. controls ARMS vs. controls Mean (S.D.) Mean (S.D.) Mean (S.D.) B (95% CI) p B (95% CI) p Stress Event 3.70 (0.77) 3.53 (0.74) 3.24 (0.69) 0.46 (0.37 0.55) <0.001 0.29 (0.19 0.38) <0.001 Activity 3.42 (0.90) 3.15 (0.78) 3.0 (0.50) 0.43 (0.34 0.52) <0.001 0.15 (0.07 0.24) 0.001 Social 3.48 (0.89) 2.91 (0.84) 2.66 (0.72) 0.83 (0.72 0.92) <0.001 0.25 (0.15 0.34) <0.001 Negative affect 3.04 (1.23) 3.0 (1.08) 1.91 (0.70) 1.13 (1.05 1.21) <0.001 1.10 (1.02 1.18) <0.001 2.87 (1.27) 2.40 (1.13) 2.19 (1.22) 0.68 (0.59 0.77) <0.001 0.21 (0.12 0.31) <0.001 2.62 (1.25) 2.97 (1.33) 1.87 (0.84) 0.75 (0.65 0.85) <0.001 1.11 (1.01 1.21) <0.001 2.55 (1.27) 2.40 (1.13) 1.47 (0.59) 1.08 (1.01 1.15) <0.001 0.93 (0.86 1.01) <0.001 Note: ESM, Experience Sampling Method; FEP, First-Episode Psychosis; ARMS, At-Risk Mental State for psychosis; S.D., standard deviation; CI, confidence interval

Supplementary Table 3. Multivariate multilevel model correlations at beep level between the variables, negative affect, psychotic, threat, aberrant, controlled for age and gender. FEP UHR Controls Association CC SE 95% CI CC SE 95% CI CC SE 95% CI Event-related & negative affect 0.142 0.023 0.096-0.187 0.220 0.023 0.175-0.264 0.186 0.020 0.146-0.224 Social & negative affect 0.217 0.022 0.173-0.261 0.294 0.022 0.251-0.336 0.322 0.018 0.285-0.357 Activity & negative affect 0.321 0.021 0.279-0.362 0.403 0.020 0.363-0.442 0.376 0.018 0.341-0.410 Event-related & threat 0.096 0.023 0.050-0.142 0.146 0.023 0.010-0.191 0.121 0.020 0.082-0.161 Social & threat 0.113 0.023 0.067-0.159 0.186 0.023 0.140-0.230 0.127 0.020 0.087-0.166 Activity & threat 0.173 0.023 0.128-0.218 0.278 0.022 0.235-0.321 0.223 0.019 0.191-0.267 Event-related & aberrant -0.091 0.023-0.137- -0.045-0.021 0.024-0.069-0.026-0.019 0.021-0.059-0.021 Social & aberrant -0.022 0.024-0.068-0.025-0.004 0.024-0.051-0.043-0.007 0.021-0.047-0.033 Activity & aberrant -0.010 0.024-0.056-0.037 0.053 0.024 0.006-0.099 0.013 0.021-0.027-0.053 Event-related & psychotic 0.079 0.024 0.033-0.125 0.096 0.024 0.050-0.143 0.092 0.020 0.052-0.132 Social & psychotic 0.068 0.024 0.022-0.114 0.188 0.023 0.142-0.233 0.182 0.020 0.143-0.221 Activity & psychotic 0.227 0.022 0.183-0.271 0.284 0.022 0.241-0.327 0.212 0.020 0.173-0.250 & negative affect 0.099 0.023 0.052-0.144 0.059 0.024 0.012-0.105 0.061 0.020 0.021-0.101 & negative affect 0.249 0.022 0.205-0.292 0.830 0.051 0.699-0.907 0.265 0.019 0.228-0.302 & negative affect 0.464 0.019 0.427-0.500 0.482 0.018 0.446-0.518 0.464 0.016 0.432-0.495 & psychotic 0.262 0.022 0.218-0.304 0.214 0.023 0.169-0.259 0.237 0.019 0.198-0.274 & aberrant 0.018 0.024-0.028-0.065 0.011 0.024-0.036-0.057 0.076 0.020 0.036-0.116 & aberrant 0.311 0.021 0.269-0.353 0.335 0.021 0.293-0.376 0.286 0.019 0.249-0.323 Note. CC, correlation coefficient; SE, standard error; 95% CI, 95% confidence interval

FEP ARMS Controls (a) 0.05* 0.02** 0.04** 0.22** Event -0.08* 0.16** Event Event 0.04** 0.03** (b) 0.13** 0.22** Activity Activity Activity 0.13** 0.08** 0.14** 0.03** (c) 0.07** 0.07** 0.10** 0.22** Social 0.07** Social Social 0.10** 0.08** 0.03** Supplementary Figure 1. Display of individual path coefficients for significant indirect effects (i.e., the product of individual path coefficients; shown in Table 3) of (a) event-related, (b) activity-related, and (c) social on psychotic via affective ( ), aberrant ( ), threat ( ), and via affective and threat ( ). Findings are displayed separately for FEP individuals, ARMS individuals, and controls. * P<0.05; ** P<0.001

Online Supplementary Methods Statistical analysis ESM data have a multilevel structure, such that multiple observations are nested within subjects. Multilevel moderated mediation models were fitted in MPlus, Version 7, 38 to control for within-subject clustering of multiple observations, 39, 42 using the MLR estimator, which allows for the use of all available data under the relatively unrestrictive assumption that data is missing at random if all variables associated with missing values are included in the model. In a two-level model, multiple observations (level-1) were treated as nested within subjects (level-2). The total effect of ful contexts and (event-related, activity-related, and social ) in daily life (level-1) on intensity of psychotic (level-1) was apportioned into direct and indirect (or, synonymously, mediating) effects through negative affect, aberrant, and enhanced threat (level-1) using the product of coefficients strategy. This strategy quantifies the point estimate of the indirect effect as the product of the coefficient of independent variable on mediator variable (path a) and the coefficient of mediator variable on dependent variable (path b). We used statistical software by Selig and Preacher 41 for computing Monte Carlo confidence intervals and assessing statistical significance of indirect effects, given their advantages over rival methods in the context of multiple multilevel mediation models. 40, 42 Group (FEP, ARMS, controls) was used as the moderator variable (level-2) of direct and conditional indirect effects in all analyses based on a multilevel moderated mediation approach, in which the moderator variable is the predictor of the a and b paths (see above) and the strength of the indirect effect of the level-1 independent variable depends on the level-2 moderator variable. 40, 54 This allowed us to test whether conditional indirect effects were greater in a) FEP than in controls, b) ARMS than in controls, and c) FEP than in ARMS by computing differences in conditional indirect effects using the model constraint command in MPlus 38 and calculating

respective Monte Carlo confidence intervals. 40, 39 We first fitted separate simple moderated multilevel mediation models (including variables associated with missing values (i.e., age, group) 12 ): 1) with one independent variable for event-related, activity-related, or social, one mediator variable for negative affect, threat or aberrant, and one outcome variable for psychotic ; 2) with one independent variable for negative affect, one mediator variable for threat or aberrant, and one outcome variable for psychotic ; and 3) with enhanced threat as independent variable, aberrant as mediator variable, and psychotic as outcome variable. Based on evidence of mediation via negative affect, threat and aberrant in these models, we next fitted a multiple multilevel moderated mediation model to examine the relative contribution of direct effects and specific indirect effects via these pathways simultaneously. 42 All analyses were adjusted for age, gender, ethnicity, level of education, employment status and, based on findings from previous ESM research, 12 arearelated and outsider status as potential confounders by including these variables as predictors of each mediator and dependent variable.